A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.
Stewart
A K
AK
Department of Medicine, University of Toronto, Ontario.
Lassam
N J
NJ
Graham
F L
FL
Gauldie
J
J
Addison
C L
CL
Bailey
D J
DJ
Dessureault
S
S
Dubé
I D
ID
Gallenger
S
S
Krajden
M
M
Rotstein
L E
LE
Quirt
I C
IC
Moen
R
R
D000256:Adenoviridae / Q000235:genetics* / Q000502:physiology; D000257:Adenoviridae Infections / Q000209:etiology / Q000635:transmission; D000818:Animals; D001943:Breast Neoplasms / Q000628:therapy*; D002985:Clinical Protocols; D004195:Disease Models, Animal; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods* / Q000592:standards; D005822:Genetic Vectors; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*; D051379:Mice; D008822:Mice, Transgenic; D010865:Pilot Projects; D012307:Risk Factors; D014779:Virus Replication
D007376:Interleukin-2